News Archive
Center for Myotonic Dystrophy Research Draws a Step Closer with Private Foundation Support
ALBANY, N.Y. - The RNA Institute has been awarded seed funding from The Marigold Foundation to help develop a Center for Myotonic Dystrophy. It will serve as a hub for academic, clinical and industrial collaborative partnerships to increase research, educational and clinical opportunities in myotonic dystrophy (DM).
Cluster Investigation of COVID-19
The current COVID-19 pandemic has spurred a major collaboration between researchers at SUNY Upstate Medical University led by Dr. Frank Middleton and The RNA Institute at the University at Albany – SUNY, led by Dr. Andrew Berglund. Combining the clinical and diagnostic expertise at Upstate with the research experts at the RNA Institute, the two groups seek to address fundamental questions about the disease including: How does the disease spread amongst newly-diagnosed cases? Are some patients resistant to infection? How are New York State residents recovering from this disease? Answering these questions now will help doctors and researchers protect the health and welfare of New York State residents, including SUNY students and employees statewide, as well as the communities in which they reside.
RAPID Award for the development of a Rapid SARS-CoV2 Test
The Halvorsen Lab at the RNA Institute at the University At Albany was recently awarded an NSF grant for Rapid Response Research (RAPID) to develop an alternative diagnostic test for SARS-CoV-2 using DNA nanoswitches.
New “miRacles” for Human Health
Two RNA Institute scientists produce a nanotechnology approach that detects disease biomarkers at lower cost.
New Therapies Being Developed for Children with Muscular Dystrophy Are Offering Hope
Dey, a faculty researcher at The RNA Institute at the University at Albany, was recently awarded the American Heart Association’s (AHA) prestigious Scientist Development Grant to gain a better understanding of DMD and develop RNA-based therapy treatments that can potentially fight the disease.
Heart Association Awards Grant to University Scientist for Development of New Duchenne Therapies
The American Heart Association (AHA) has awarded its distinguished Scientist Development Grant to a University at Albany researcher for the development of new therapies to treat Duchenne muscular dystrophy (DMD). Bijan K. Dey, PhD, is a faculty researcher at the university’s RNA Institute and is working on a class of small non-coding RNA molecules called microRNAs. His lab is studying how microRNAs maintain normal muscle function and what goes wrong when children are diagnosed with Duchenne MD and associated heart conditions.
Scientist Awarded AHA Grant to Develop Therapies for Rare Form of Childhood Muscular Dystrophy
Scientist Bijan K. Dey could soon offer hope to young patients with a rare form of muscular dystrophy.